title: Single-unit responses of serotonergic neurons to vasoactive drug administration in behaving cats.
abstract: Single-unit activity of serotonergic neurons in the dorsal raphe nucleus (DRN), heart rate (HR), and arterial blood pressure were recorded in freely moving cats during spontaneous behavior and in response to systemic administration of vasoactive drugs. The activity of serotonergic neurons varied in association with behavioral arousal but was unrelated to spontaneous fluctuations in HR and blood pressure. Bolus administration of phenylephrine hydrochloride and sodium nitroprusside (15-20 micrograms/kg iv) produced a rapid transient increase (35 mmHg) and decrease (49 mmHg), respectively, in mean arterial pressure (MAP). Infusion of phenylephrine and sodium nitroprusside (100 micrograms/ml) produced sustained hypertension (avg MAP 166 mmHg) and hypotension (avg MAP 49 mmHg), respectively. The activity of serotonergic neurons was not significantly altered in response to phenylephrine or sodium nitroprusside administration. Furthermore, no significant changes in unit activity were observed after hydralazine administration (1 mg/kg iv) despite prolonged reflex activation of sympathetic outflow. Thus the activity of DRN serotonergic neurons was unrelated to transient alterations in blood pressure and baroreceptor activity. These results suggest that changes in the activity of serotonergic DRN neurons are not involved in physiological mechanisms underlying reflex alterations in sympathetic (and parasympathetic) outflow invoked by hypertension and hypotension.
authors: Department of Psychology, Princeton University, New Jersey 08544.
authors: C A
authors: CA
authors: Fornal
authors: W J
authors: WJ
authors: Litto
authors: D A
authors: DA
authors: Morilak
authors: B L
authors: BL
authors: Jacobs
mesh_terms: D017371:8-Hydroxy-2-(di-n-propylamino)tetralin; D000818:Animals; D001522:Behavior, Animal; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006830:Hydralazine / Q000494:pharmacology; D007275:Injections, Intravenous; D008297:Male; D008732:Methoxydimethyltryptamines / Q000494:pharmacology; D009474:Neurons / Q000187:drug effects* / Q000502:physiology; D009599:Nitroprusside / Q000494:pharmacology*; D010656:Phenylephrine / Q000494:pharmacology*; D011903:Raphe Nuclei / Q000166:cytology / Q000502:physiology; D012701:Serotonin / Q000502:physiology*; D012702:Serotonin Antagonists / Q000494:pharmacology; D012894:Sleep Stages / Q000187:drug effects / Q000502:physiology; D013764:Tetrahydronaphthalenes / Q000494:pharmacology
chemical_list: D008732:Methoxydimethyltryptamines; D012702:Serotonin Antagonists; D013764:Tetrahydronaphthalenes; D009599:Nitroprusside; D010656:Phenylephrine; D006830:Hydralazine; D012701:Serotonin; D017371:8-Hydroxy-2-(di-n-propylamino)tetralin